Clinical treatment of opioid addiction and dependence.
Ling
Walter
W
Integrated Substance Abuse Programs, University of California Los Angeles, Los Angeles, CA, USA.
Rawson
Richard A
RA
Compton
Margaret
M
D000284:Administration, Oral; D000286:Administration, Sublingual; D002047:Buprenorphine / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008658:Inactivation, Metabolic; D008691:Methadone / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology / Q000627:therapeutic use*; D008692:Methadyl Acetate / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D009271:Naltrexone / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000188:drug therapy* / Q000523:psychology / Q000534:rehabilitation
D009292:Narcotic Antagonists; D002047:Buprenorphine; D009271:Naltrexone; D008692:Methadyl Acetate; D008691:Methadone